X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4137) 4137
Book Review (1567) 1567
Publication (549) 549
Book / eBook (216) 216
Book Chapter (103) 103
Conference Proceeding (30) 30
Reference (7) 7
Dissertation (5) 5
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3667) 3667
animals (2834) 2834
humans (1994) 1994
male (1090) 1090
neurosciences (992) 992
rats (952) 952
pharmacology & pharmacy (738) 738
physiology (631) 631
mice (612) 612
female (597) 597
receptors (564) 564
biochemistry & molecular biology (450) 450
endocrinology & metabolism (440) 440
vasoactive-intestinal-peptide (431) 431
physiological aspects (402) 402
research (377) 377
cell biology (374) 374
signal transduction (360) 360
peptides (345) 345
receptor (344) 344
rodents (325) 325
neurons (323) 323
cells, cultured (320) 320
neuropeptides (315) 315
rats, sprague-dawley (307) 307
expression (292) 292
proteins (286) 286
cyclase-activating polypeptide (280) 280
inflammation (277) 277
gene-related peptide (267) 267
molecular sequence data (263) 263
article (262) 262
vasoactive intestinal peptide - pharmacology (262) 262
gastroenterology & hepatology (256) 256
immunology (256) 256
amino acid sequence (254) 254
cells (251) 251
dose-response relationship, drug (249) 249
substance-p (243) 243
analysis (241) 241
rats, wistar (240) 240
in vitro techniques (235) 235
immunohistochemistry (234) 234
hormones, hormone substitutes, and hormone antagonists (230) 230
pituitary adenylate cyclase-activating polypeptide (227) 227
abridged index medicus (225) 225
central-nervous-system (220) 220
brain (219) 219
gene expression (211) 211
rat (208) 208
vasoactive intestinal polypeptide (206) 206
vip (206) 206
multidisciplinary sciences (202) 202
nervous system (202) 202
in-vitro (201) 201
neurology (201) 201
medicine & public health (199) 199
pacap (197) 197
biomedicine (187) 187
neurons - metabolism (183) 183
medicine (181) 181
vasoactive intestinal peptide - metabolism (181) 181
review (180) 180
messenger-rna (179) 179
pharmacology (179) 179
health aspects (177) 177
vasoactive intestinal peptide (176) 176
mice, inbred c57bl (175) 175
signal transduction - physiology (174) 174
gene-expression (173) 173
nitric oxide (171) 171
ligands (167) 167
nitric-oxide (167) 167
rna, messenger - metabolism (166) 166
cyclic amp - metabolism (164) 164
hormones (163) 163
nitric-oxide synthase (163) 163
adenylate-cyclase (159) 159
disease models, animal (159) 159
cytokines (150) 150
in-vivo (147) 147
activation (146) 146
secretion (144) 144
clinical neurology (142) 142
signal transduction - drug effects (142) 142
substance p (142) 142
time factors (140) 140
cancer (137) 137
cell line (136) 136
care and treatment (135) 135
neurons - drug effects (135) 135
calcium - metabolism (134) 134
adult (132) 132
peptide fragments - pharmacology (131) 131
reverse transcriptase polymerase chain reaction (130) 130
neurotransmitters (129) 129
endocrine system (128) 128
guinea pigs (128) 128
oncology (128) 128
mice, knockout (127) 127
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (174) 174
UofT at Mississauga - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Online Resources - Online (6) 6
UTL at Downsview - May be requested (6) 6
UofT at Scarborough - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4404) 4404
Spanish (14) 14
French (7) 7
Japanese (5) 5
German (4) 4
Russian (2) 2
Arabic (1) 1
Chinese (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cephalalgia, ISSN 0333-1024, 1/2011, Volume 31, Issue 2, pp. 181 - 189
Objective: We pharmacologically characterized pituitary adenylate cyclase–activating polypeptides (PACAPs), vasoactive intestinal peptide (VIP) and the VPAC1,... 
PAC1 | PACAP38 | VPAC1 | VIP | VPAC2 | CYCLASE-ACTIVATING POLYPEPTIDE | RAT | IMMUNOHISTOCHEMICAL LOCALIZATION | MIGRAINE | NEUROSCIENCES | PEPTIDE | CLINICAL NEUROLOGY | PAC | VPAC | MESSENGER-RNA | HEADACHE | CEREBRAL-ARTERIES | HEALTHY-VOLUNTEERS | EXPRESSION | Pituitary Adenylate Cyclase-Activating Polypeptide - antagonists & inhibitors | Receptors, Vasoactive Intestinal Polypeptide, Type I - antagonists & inhibitors | Gene Expression - drug effects | Receptors, Vasoactive Intestinal Peptide, Type II - agonists | Humans | Middle Aged | Male | Peptide Fragments - pharmacology | Receptors, Vasoactive Intestinal Peptide - genetics | RNA, Messenger - metabolism | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Meningeal Arteries - physiology | Vasoactive Intestinal Peptide - pharmacology | Receptors, Vasoactive Intestinal Polypeptide, Type I - agonists | Gene Expression - physiology | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Migraine Disorders - physiopathology | Adult | Female | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - agonists | Vasodilation - physiology | Coronary Vessels - drug effects | Receptors, Vasoactive Intestinal Peptide, Type II - antagonists & inhibitors | Vasodilator Agents - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - genetics | Coronary Vessels - physiology | Pituitary Adenylate Cyclase-Activating Polypeptide - adverse effects | Meningeal Arteries - drug effects | Migraine Disorders - drug therapy | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Aged | Receptors, Vasoactive Intestinal Peptide - antagonists & inhibitors | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Vasodilation - drug effects | Receptors, Vasoactive Intestinal Peptide - agonists | Vasoactive Intestinal Peptide - analogs & derivatives | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - antagonists & inhibitors | Index Medicus
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 07/2012, Volume 55, Issue 13, pp. 6137 - 6148
Journal Article
Pain, ISSN 0304-3959, 2006, Volume 123, Issue 1, pp. 98 - 105
Osteoarthritis (OA) is a debilitating disease in which primarily weight-bearing joints undergo progressive degeneration. Despite the widespread prevalence of... 
Neuropeptides | Algesiometry | Monoiodoacetate | Joint pain | Osteoarthritis | Incapacitance | CAT KNEE-JOINT | SYNOVIAL-FLUID | osteoarthritis | MAST-CELLS | MECHANOSENSITIVITY | incapacitance | neuropeptides | joint pain | ARTHRITIS | NEUROSCIENCES | CLINICAL NEUROLOGY | monoiodoacetate | algesiometry | HISTAMINE LEVELS | ANESTHESIOLOGY | SUBSTANCE-P | RECEPTORS | POLYPEPTIDE | AFFERENTS | Hindlimb | Receptors, Vasoactive Intestinal Polypeptide, Type I - antagonists & inhibitors | Rats, Wistar | Stress, Mechanical | Male | Peptide Fragments - pharmacology | Vasoactive Intestinal Peptide - administration & dosage | Iodoacetates - toxicity | Receptors, Vasoactive Intestinal Peptide, Type II - physiology | Vasoactive Intestinal Peptide - pharmacology | Vasoactive Intestinal Peptide - physiology | Pain - etiology | Pain Threshold - drug effects | Drug Evaluation, Preclinical | Iodoacetates - administration & dosage | Disease Models, Animal | Vasoactive Intestinal Peptide - therapeutic use | Stifle | Receptors, Vasoactive Intestinal Peptide, Type II - antagonists & inhibitors | Rats | Receptors, Vasoactive Intestinal Polypeptide, Type I - physiology | Hyperalgesia - physiopathology | Animals | Pain - physiopathology | Injections, Intra-Articular | Vasoactive Intestinal Peptide - toxicity | Hyperalgesia - etiology | Weight-Bearing | Peptide Fragments - therapeutic use | Osteoarthritis, Knee - physiopathology | Vasoactive intestinal peptides | Rheumatoid arthritis | Arthralgia | Index Medicus
Journal Article
Journal Article
Journal Article
Neuropharmacology, ISSN 0028-3908, 2006, Volume 51, Issue 6, pp. 1086 - 1098
Journal Article
Peptides, ISSN 0196-9781, 2010, Volume 31, Issue 8, pp. 1517 - 1522
Recent studies have suggested the potential use of vasoactive intestinal peptide (VIP) in the treatment of pulmonary arterial hypertension (PAH). An... 
Proliferation | VPAC1 | Vasoactive intestinal peptide | VPAC2 | VASOACTIVE-INTESTINAL-PEPTIDE | PACAP | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECEPTOR | GENE | PHARMACOLOGY | ENDOCRINOLOGY & METABOLISM | PHARMACOLOGY & PHARMACY | TISSUES | HYPERTENSION | Immunohistochemistry | Receptors, Vasoactive Intestinal Polypeptide, Type I - antagonists & inhibitors | Hypertension, Pulmonary - physiopathology | Male | Peptide Fragments - pharmacology | Aorta - metabolism | RNA, Messenger - metabolism | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Receptors, Vasoactive Intestinal Peptide, Type II - physiology | Pulmonary Artery - metabolism | Vasoactive Intestinal Peptide - physiology | Hypertension, Pulmonary - drug therapy | Cyclic AMP - metabolism | Gene Expression | Receptors, Vasoactive Intestinal Peptide, Type II - antagonists & inhibitors | Cells, Cultured | Myocytes, Smooth Muscle - physiology | Rats | Receptors, Vasoactive Intestinal Polypeptide, Type I - physiology | Reverse Transcriptase Polymerase Chain Reaction | Rats, Sprague-Dawley | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Blotting, Western | Pulmonary Artery - cytology | Animals | Cell Proliferation - drug effects | Aorta - cytology | Respiratory agents | G proteins | Vasoactive intestinal peptides | Pulmonary hypertension | Protein binding | Polyallylamine hydrochloride | Receptors | Peptides | Muscles | Aorta | Inhibition | Nucleotides | Arteries | Index Medicus
Journal Article
Journal of Applied Physiology, ISSN 8750-7587, 07/2010, Volume 109, Issue 1, pp. 95 - 100
Journal Article
Journal of Applied Physiology, ISSN 8750-7587, 11/2012, Volume 113, Issue 10, pp. 1512 - 1518
Kellogg DL Jr, Zhao JL, Wu Y, Johnson JM. Nitric oxide and receptors for VIP and PACAP in cutaneous active vasodilation during heat stress in humans. J Appl... 
CYCLASE-ACTIVATING POLYPEPTIDE | SPORT SCIENCES | PHYSIOLOGY | VASOACTIVE-INTESTINAL-PEPTIDE | SYNTHASE CONTROL MECHANISMS | VASCULAR-RESPONSES | laser-Doppler flowmetry | thermoregulation | EXERCISE | INHIBITION | microdialysis | ROLES | PHARMACOLOGY | VPAC2 | IN-VIVO | PAC1 | SKIN BLOOD-FLOW | Blood Vessels - metabolism | Humans | Nitric Oxide Synthase - antagonists & inhibitors | Male | Peptide Fragments - pharmacology | Nitroprusside - pharmacology | Heat Stress Disorders - physiopathology | Blood Vessels - physiopathology | Arterial Pressure | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Adult | Female | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | NG-Nitroarginine Methyl Ester - pharmacology | Heart Rate | Receptors, Vasoactive Intestinal Peptide, Type II - antagonists & inhibitors | Vasodilator Agents - pharmacology | Receptors, Vasoactive Intestinal Peptide, Type II - metabolism | Body Temperature Regulation | Enzyme Inhibitors - pharmacology | Heat Stress Disorders - metabolism | Laser-Doppler Flowmetry | Regional Blood Flow | Skin - blood supply | Heat-Shock Response | Microdialysis | Analysis of Variance | Blood Flow Velocity | Nitric Oxide Synthase - metabolism | Vasodilation - drug effects | Nitric Oxide - metabolism | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - antagonists & inhibitors | Blood pressure | Polypeptides | Nitric oxide | Body temperature | Medical treatment | Index Medicus
Journal Article
American Journal of Physiology - Gastrointestinal and Liver Physiology, ISSN 0193-1857, 10/2009, Volume 297, Issue 4, pp. 716 - 725
We tested the hypothesis that spontaneous release of vasoactive intestinal peptide (VIP) from enteric neurons maintains homeostasis in smooth muscle function... 
Inflammatory bowel disease | NF-κB | Inflammation | Vasoactive intestinal peptide receptors | NERVE-FIBERS | ACTIVATION | PHYSIOLOGY | VASOACTIVE-INTESTINAL-PEPTIDE | CROHNS-DISEASE | vasoactive intestinal peptide receptors | inflammatory bowel disease | CIRCULAR MUSCLE | NF-kappa B | EXPERIMENTAL COLITIS | inflammation | SUBSTANCE-P | GASTROENTEROLOGY & HEPATOLOGY | NF-KAPPA-B | INFLAMMATORY BOWEL-DISEASE | TRANSCRIPTIONAL REGULATION | Enteric Nervous System - drug effects | Humans | Colon - drug effects | Colon - immunology | Colon - innervation | NF-kappa B - metabolism | Vasoactive Intestinal Peptide - administration & dosage | Muscle, Smooth - drug effects | Time Factors | Vasoactive Intestinal Peptide - pharmacology | Binding Sites | Disease Models, Animal | Receptors, Vasoactive Intestinal Peptide, Type II - antagonists & inhibitors | Muscle, Smooth - innervation | Enteric Nervous System - metabolism | Rats | Enteric Nervous System - immunology | Rats, Sprague-Dawley | Muscle Contraction | Colitis - metabolism | Calcium Channels, L-Type - metabolism | Colitis - prevention & control | Tumor Necrosis Factor-alpha - metabolism | Vasoactive Intestinal Peptide - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - antagonists & inhibitors | Homeostasis | I-kappa B Proteins - metabolism | Trinitrobenzenesulfonic Acid | Muscle, Smooth - immunology | Dose-Response Relationship, Drug | Enteric Nervous System - physiopathology | Transfection | Colitis - chemically induced | Inflammation Mediators - metabolism | Colon - physiopathology | Receptors, Vasoactive Intestinal Polypeptide, Type I - metabolism | Active Transport, Cell Nucleus | Colitis - immunology | Promoter Regions, Genetic | Acetylcholine - pharmacology | Receptors, Vasoactive Intestinal Peptide, Type II - metabolism | Cells, Cultured | Hormone Antagonists - pharmacology | Infusions, Subcutaneous | Animals | Calcium Channels, L-Type - genetics | Colitis - physiopathology | Muscle, Smooth - physiopathology | In Vitro Techniques | Neuroimmunomodulation - drug effects | Care and treatment | Physiological aspects | Smooth muscle | Research | Vasoactive intestinal peptides | Risk factors | Tissue | Peptides | Neurons | Colon | Cells | Binding sites | Index Medicus | Neuroregulation and Motility
Journal Article
Journal Article
Journal of Molecular Neuroscience, ISSN 0895-8696, 11/2012, Volume 48, Issue 3, pp. 674 - 683
Malignant peripheral nerve sheath tumors (MPNSTs) are sarcomas able to grow under conditions of met